Narrow your search
Listing 1 - 10 of 25 << page
of 3
>>
Sort by

Dissertation
Approche préventive et thérapeutique des décompensations cardiaques secondaires aux cardiomyopathies hypertrophiques félines : aspects théoriques et pratiques
Authors: --- --- --- ---
Year: 2021 Publisher: Liège Université de Liège (ULiège)

Loading...
Export citation

Choose an application

Bookmark

Abstract

La cardiomyopathie hypertrophique correspond à la cardiopathie la plus prévalente chez le chat, incitant les vétérinaires à accorder une importance particulière à sa gestion thérapeutique. Pourtant, une étude réalisée il y’a dix ans soulignait un déficit de littérature concernant l’approche médicale de cette pathologie, imposant aux vétérinaires de réaliser leur prise de décision pharmacothérapeutique sur base d’effets théoriques probablement bénéfiques, de leurs expériences personnelles favorables ou de simples transpositions d’effets bénéfiques observés chez l’homme ou chez le chien. Le but de ce travail est de dresser un nouvel état des lieux, dix ans plus tard, des avancées de la communauté scientifique concernant la prise en charge de cette pathologie très fréquente dans l’espèce féline.&#13;Pour cela, nous commencerons par rappeler brièvement la pathophysiologie de cette maladie de façon à mettre en lumière les objectifs thérapeutiques et ainsi les familles pharmacologiques pouvant théoriquement être envisagées pour répondre à ceux-ci. Par la suite, nous passerons en revue la bibliographie relative à chacune de ces familles, en abordant pour chacune leur impact sur l’amélioration de la durée de vie et de la qualité de vie, puis nous soulèverons les questions relatives aux aspects pratiques de leur utilisation (possibilités d’optimisation de la compliance des propriétaires par le biais d’une adaptation de la posologie ou de la forme galénique). Enfin, nous conclurons en résumant les données disponibles au sein de la littérature et en proposant un schéma global de gestion thérapeutique pour chacun des stades de cette pathologie, incluant les aspects théoriques, bibliographiques et pratiques permettant d’optimiser la durée de vie et la qualité de vie des chats atteints de cardiomyopathie hypertrophique féline primaire. Hypertrophic cardiomyopathy is the most prevalent cardiac disease in cats, prompting veterinarians to take a close look at its therapeutic management. A study carried out ten years ago revealed however an important lack of information in the scientific literature concerning the medical approach of this pathology. This deficiency left veterinarians to rely solely on the supposedly positive effects of certain medicines, personal experience or extrapolations from human or dog therapy to make their pharmacotherapeutic decision when dealing with hypertrophic cardiomyopathy in cats. In this paper, we draw up the current state of play, ten years later, on the advances of the scientific community regarding the treatment of this frequent disease in feline species.&#13;To achieve this, we will begin by briefly recalling the pathophysiology of this disease to highlight the therapeutic goals and pharmacological families that could be theoretically efficient in the case of hypertrophic cardiomyopathy. We will then make a review of the existing bibliography for each of these families by addressing their impact on the improvement of lifespan and quality of life, and by raising questions about the practicalities of their use (opportunities for optimizing the owners’ compliance through an adaptation of the dosage or the galenic formulation). Finally, we will conclude by summarizing the available data in the literature and we will suggest a comprehensive therapeutic management scheme for each stage of this pathology, including the theoretical, bibliographic and practical aspects allowing for the optimization of the lifespan and quality of life of cats with primary feline hypertrophic cardiomyopathy.


Periodical
European journal of heart failure. : journal of the Working Group on Heart Failure of the European Society of Cardiology.
Author:
ISSN: 18781314 Year: 2002 Publisher: Amsterdam ; New York : Elsevier,

Congestive heart failure : mechanisms, evaluation and treatment
Author:
ISBN: 0914316052 9780914316053 Year: 1976 Publisher: New York (N.Y.): Dun-Donnelley


Book
Heart failure
Authors: ---
ISBN: 9780323609883 0323609880 0323609880 0323609872 9780323609890 0323609899 9780323609876 Year: 2020 Publisher: Philadelphia, PA

Loading...
Export citation

Choose an application

Bookmark

Abstract

Up-to-date, authoritative and comprehensive, Heart Failure, 4th Edition, provides the clinically relevant information you need to effectively manage and treat patients with this complex cardiovascular problem. This fully revised companion to Braunwald's Heart Disease helps you make the most of new drug therapies such as angiotensin receptor neprilysin inhibitors (ARNIs), recently improved implantable devices, and innovative patient management strategies. Led by internationally recognized heart failure experts Dr. G. Michael Felker and Dr. Douglas Mann, this outstanding reference gives health care providers the knowledge to improve clinical outcomes in heart failure patients. Focuses on a clinical approach to treating heart failure, resulting from a broad variety of cardiovascular problems. Covers the most recent guidelines and protocols, including significant new updates to ACC, AHA, and HFSA guidelines. Covers key topics such as biomarkers and precision medicine in heart failure and new data on angiotensin receptor neprilysin inhibitors (ARNIs). Contains four new chapters: Natriuretic Peptides in Heart Failure; Amyloidosis as a Cause of Heart Failure; HIV and Heart Failure; and Neuromodulation in Heart Failure. Covers the pathophysiological basis for the development and progression of heart failure. Serves as a definitive resource to prepare for the ABIM's Heart Failure board exam. 2016 British Medical Association Award: First Prize, Cardiology (3rd Edition). Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.


Periodical
International journal of heart failure
Author:
ISSN: 26361558 Year: 2019 Publisher: Seoul : Korean Society of Heart Failure,

Listing 1 - 10 of 25 << page
of 3
>>
Sort by